![A common mechanism allows selective targeting of GluN2B subunit-containing N-methyl-D-aspartate receptors | Communications Biology A common mechanism allows selective targeting of GluN2B subunit-containing N-methyl-D-aspartate receptors | Communications Biology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs42003-019-0645-6/MediaObjects/42003_2019_645_Fig9_HTML.png)
A common mechanism allows selective targeting of GluN2B subunit-containing N-methyl-D-aspartate receptors | Communications Biology
![First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-d-aspartate Receptor with (R)-11C-Me-NB1 | Journal of Nuclear Medicine First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-d-aspartate Receptor with (R)-11C-Me-NB1 | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/63/6/936/F1.large.jpg)
First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-d-aspartate Receptor with (R)-11C-Me-NB1 | Journal of Nuclear Medicine
A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 Receptor | Journal of Medicinal Chemistry
![The differences between GLP1a non-insulin injectables: which one is right for you? - My Diabetes Lifestyle The differences between GLP1a non-insulin injectables: which one is right for you? - My Diabetes Lifestyle](https://i2.wp.com/www.mydiabeteslifestyle.com/wp-content/uploads/2022/02/glp1a-injectables.jpg?fit=767%2C610&ssl=1)